Company news

Genscript Biotech Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Voluntary announcement: legend announces preliminary sales for CARVYKTI for the quarter ended 30 September 2026

October 13, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

October 6, 2026

Change in board lot size

September 21, 2026

Announcement pursuant to rule 13.10 of the listing rules

September 17, 2026

List of directors and their role and function

September 16, 2026

Passing away of an independent non-executive director and change in composition of board committees

September 16, 2026

Interim report 2026

September 16, 2026

Next Day Disclosure Return

September 15, 2026

Completion of placing of new shares under the general mandate

September 15, 2026

GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

August 18, 2026

GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report

April 14, 2026

GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era

April 9, 2026

GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

March 16, 2026

GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco

January 29, 2026

GenScript is Scripting Possibilities in AI-Driven Drug Discovery as Wet-Lab Partner for Latent-X2 Innovation

January 28, 2026

'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week

January 6, 2026

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

November 22, 2025

GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation

August 17, 2025

GenScript Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology

August 8, 2025

GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader

July 31, 2025

GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability

July 9, 2025

ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy

June 27, 2025

GenScript Biotech Corporation Reports FY 2024 Results

March 12, 2025

Calls

Decks